Glucosylsphingosine (lyso-GL1) is a biomarker used to monitor disease and treatment response in Gaucher disease. Data from adults show that higher values of lyso-GL1 are associated with increased disease progression, however similar data in the pediatric population is lacking. In a cohort of pediatric patients, we present a relationship between lyso-GL1 value and Gaucher type, age, and treatment response. Data from this study may serve as a reference for providers monitoring children with Gaucher disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ymgme.2023.107736 | DOI Listing |
Publication Analysis
Top Keywords
gaucher disease
12
glucosylsphingosine lyso-gl1
8
cohort pediatric
8
pediatric patients
8
treatment response
8
disease
5
treatment-naive post-treatment
4
post-treatment glucosylsphingosine
4
lyso-gl1
4
lyso-gl1 levels
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!